Loading clinical trials...
Loading clinical trials...
Aim of these study is to create an algorithm, using data from patients that undergoing total hip arthroplasty, to predict blood loss after surgery and permit a safe domestic discharge.
Two different cohorts of patients undergoing total hip arthroplasty will be analyzed to obtain data about hemoglobin trends. The first group will be used to obtain the algorithm, the second one to validate results of the first group, determining sensitivity and specificity.
Age
All ages
Sex
ALL
Healthy Volunteers
No
Start Date
April 1, 2016
Primary Completion Date
April 1, 2016
Completion Date
May 1, 2016
Last Updated
April 26, 2016
124
ACTUAL participants
Total hip arthroplasty, blood loss analysis
PROCEDURE
Lead Sponsor
Azienda Ospedaliera Bolognini di Seriate Bergamo
NCT06238960
NCT06403163
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions